QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
Log in
NYSEARCA:HELX

Franklin Genomic Advancements ETF Stock Forecast, Price & News

$36.79
-0.40 (-1.08 %)
(As of 10/26/2020 12:00 AM ET)
Add
Today's Range
$36.69
Now: $36.79
$37.31
50-Day Range
$32.64
MA: $35.53
$38.59
52-Week Range
$18.41
Now: $36.79
$39.93
Volume2,626 shs
Average Volume3,518 shs
Market Capitalization$3.68 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Geographic Exposure of HELX

Currency Exposure of HELX

Sector Exposure of HELX

Industry Exposure of HELX

Basic Details

Issuer Franklin Templeton Investments
Fund NameFranklin Genomic Advancements ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:HELX
Inception Date2/25/2020
Fund ManagerMatthew J.Moberg, Joyce Lin
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
Benchmark
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$3.79 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.50%
Other Expenses0.27%
Total Expenses0.77%
Fee Waiver-0.27%
Net Expenses0.55%

Administrator, Advisor and Custodian

AdministratorFranklin Templeton Services, LLC
AdvisorFranklin Advisers, Inc.
CustodianState Street Bank and Trust Company
DistributorFranklin Templeton Distributors, Inc.
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker
$36.79
-0.40 (-1.08 %)
(As of 10/26/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HELX News and Ratings via Email

Sign-up to receive the latest news and ratings for HELX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Franklin Genomic Advancements ETF (NYSEARCA:HELX) Frequently Asked Questions

How has Franklin Genomic Advancements ETF's stock been impacted by COVID-19 (Coronavirus)?

Franklin Genomic Advancements ETF's stock was trading at $23.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HELX shares have increased by 58.8% and is now trading at $36.7925.
View which stocks have been most impacted by COVID-19
.

What other stocks do shareholders of Franklin Genomic Advancements ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Franklin Genomic Advancements ETF investors own include ABIOMED (ABMD), Catalent (CTLT), Hologic (HOLX), Merck & Co., Inc. (MRK), Net Element (NETE), Novavax (NVAX), Quanterix (QTRX), Arca Biopharma (ABIO), AbbVie (ABBV) and Audioeye (AEYE).

What is Franklin Genomic Advancements ETF's stock symbol?

Franklin Genomic Advancements ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "HELX."

How do I buy shares of Franklin Genomic Advancements ETF?

Shares of HELX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Franklin Genomic Advancements ETF's stock price today?

One share of HELX stock can currently be purchased for approximately $36.79.

How big of a company is Franklin Genomic Advancements ETF?

Franklin Genomic Advancements ETF has a market capitalization of $3.68 million.

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.